These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 34665905)
41. Uricase-Deficient Larval Zebrafish with Elevated Urate Levels Demonstrate Suppressed Acute Inflammatory Response to Monosodium Urate Crystals and Prolonged Crystal Persistence. Linnerz T; Sung YJ; Rolland L; Astin JW; Dalbeth N; Hall CJ Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553446 [TBL] [Abstract][Full Text] [Related]
42. Study on the anti-gout activity of chlorogenic acid: improvement on hyperuricemia and gouty inflammation. Meng ZQ; Tang ZH; Yan YX; Guo CR; Cao L; Ding G; Huang WZ; Wang ZZ; Wang KD; Xiao W; Yang ZL Am J Chin Med; 2014; 42(6):1471-83. PubMed ID: 25384446 [TBL] [Abstract][Full Text] [Related]
43. A review on gout: Looking back and looking ahead. Tao H; Mo Y; Liu W; Wang H Int Immunopharmacol; 2023 Apr; 117():109977. PubMed ID: 37012869 [TBL] [Abstract][Full Text] [Related]
44. Icariin alleviates MSU-induced rat GA models through NF-κB/NALP3 pathway. Cao Y Cell Biochem Funct; 2021 Apr; 39(3):357-366. PubMed ID: 33135192 [TBL] [Abstract][Full Text] [Related]
45. Morin, a dietary bioflavonol suppresses monosodium urate crystal-induced inflammation in an animal model of acute gouty arthritis with reference to NLRP3 inflammasome, hypo-xanthine phospho-ribosyl transferase, and inflammatory mediators. Dhanasekar C; Rasool M Eur J Pharmacol; 2016 Sep; 786():116-127. PubMed ID: 27268719 [TBL] [Abstract][Full Text] [Related]
46. Protective effects of Rhizoma smilacis glabrae extracts on potassium oxonate- and monosodium urate-induced hyperuricemia and gout in mice. Liang G; Nie Y; Chang Y; Zeng S; Liang C; Zheng X; Xiao D; Zhan S; Zheng Q Phytomedicine; 2019 Jun; 59():152772. PubMed ID: 31005813 [TBL] [Abstract][Full Text] [Related]
48. Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. Scott P; Ma H; Viriyakosol S; Terkeltaub R; Liu-Bryan R J Immunol; 2006 Nov; 177(9):6370-8. PubMed ID: 17056568 [TBL] [Abstract][Full Text] [Related]
49. MicroRNA-155 as a proinflammatory regulator via SHIP-1 down-regulation in acute gouty arthritis. Jin HM; Kim TJ; Choi JH; Kim MJ; Cho YN; Nam KI; Kee SJ; Moon JB; Choi SY; Park DJ; Lee SS; Park YW Arthritis Res Ther; 2014 Apr; 16(2):R88. PubMed ID: 24708712 [TBL] [Abstract][Full Text] [Related]
50. Distinct macrophage polarization in acute and chronic gout. Zhao L; Ye W; Zhu Y; Chen F; Wang Q; Lv X; Hua Y; Du Z; Zhu X; Yu Y; Zou H; Liu L; Xue Y Lab Invest; 2022 Oct; 102(10):1054-1063. PubMed ID: 35614340 [TBL] [Abstract][Full Text] [Related]
51. Ameliorative Effects of Cardamonin on Monosodium Urate-Induced Gouty Arthritis through Inhibiting NLRP3 Inflammasome Mediation. Wang CC; Lu JW; Peng YJ; Lee CH; Lee HS; Chu YH; Huang CJ; Ho YJ; Liu FC; Wu CC Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577821 [No Abstract] [Full Text] [Related]
52. Pharmacological basis for use of madecassoside in gouty arthritis: anti-inflammatory, anti-hyperuricemic, and NLRP3 inhibition. Lu X; Zeng R; Lin J; Hu J; Rong Z; Xu W; Liu Z; Zeng W Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):277-284. PubMed ID: 31084401 [No Abstract] [Full Text] [Related]
53. Reduced secretion of proinflammatory cytokines of monosodium urate crystal-stimulated monocytes in chronic renal failure: an explanation for infrequent gout episodes in chronic renal failure patients? Schreiner O; Wandel E; Himmelsbach F; Galle PR; Märker-Hermann E Nephrol Dial Transplant; 2000 May; 15(5):644-9. PubMed ID: 10809805 [TBL] [Abstract][Full Text] [Related]
54. TNF-α potentiates uric acid-induced interleukin-1β (IL-1β) secretion in human neutrophils. Yokose K; Sato S; Asano T; Yashiro M; Kobayashi H; Watanabe H; Suzuki E; Sato C; Kozuru H; Yatsuhashi H; Migita K Mod Rheumatol; 2018 May; 28(3):513-517. PubMed ID: 28880687 [TBL] [Abstract][Full Text] [Related]
55. Direct Binding to NLRP3 Pyrin Domain as a Novel Strategy to Prevent NLRP3-Driven Inflammation and Gouty Arthritis. Yang G; Lee HE; Moon SJ; Ko KM; Koh JH; Seok JK; Min JK; Heo TH; Kang HC; Cho YY; Lee HS; Fitzgerald KA; Lee JY Arthritis Rheumatol; 2020 Jul; 72(7):1192-1202. PubMed ID: 32134203 [TBL] [Abstract][Full Text] [Related]
56. Comparison of the different monosodium urate crystals in the preparation process and pro-inflammation. Yan F; Zhang H; Yuan X; Wang X; Li M; Fan Y; He Y; Jia Z; Han L; Liu Z Adv Rheumatol; 2023 Aug; 63(1):39. PubMed ID: 37553684 [TBL] [Abstract][Full Text] [Related]
57. Suppressive effect of modified Simiaowan on experimental gouty arthritis: an in vivo and in vitro study. Shi L; Xu L; Yang Y; Song H; Pan H; Yin L J Ethnopharmacol; 2013 Dec; 150(3):1038-44. PubMed ID: 24184191 [TBL] [Abstract][Full Text] [Related]
59. Mechanism of Biqi capsules in the treatment of gout based on network pharmacology and experimental verification. Li G; Du S; Yan S; Wang Y; Bu R; Cheng M; Zhang Y; Chen Q; Wu Y; Zhang X; Wang D; Wang T J Ethnopharmacol; 2025 Jan; 337(Pt 1):118817. PubMed ID: 39284427 [TBL] [Abstract][Full Text] [Related]
60. Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis. Torres R; Macdonald L; Croll SD; Reinhardt J; Dore A; Stevens S; Hylton DM; Rudge JS; Liu-Bryan R; Terkeltaub RA; Yancopoulos GD; Murphy AJ Ann Rheum Dis; 2009 Oct; 68(10):1602-8. PubMed ID: 19528034 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]